Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 1

Status

Active not recruiting 3Unknown 2Completed 2Recruiting 1

Sponsor Class

OTHER 4NIH 4

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Gynecologic 5

Conditions

Uterine Cervical Neoplasms 13Papillomavirus Infections 8Uterine Cervical Dysplasia 5Stomach Neoplasms 2Neoplasms 2Atypical Squamous Cells of the Cervix 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Squamous Intraepithelial Lesions 1Spondylarthritis 1Precancerous Conditions 1Papilloma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Genital Neoplasms, Female 1Genital Diseases, Female 1Genital Diseases 1Female Urogenital Diseases and Pregnancy Complications 1Anus Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 40Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 32Papillomavirus Vaccines 24Human Papillomavirus Recombinant Vaccine nonavalent 12Vaccines 11Blood Specimen Collection 10Data Collection 9Colposcopy 9Human Papillomavirus DNA Tests 8Specimen Handling 7Radiotherapy, Intensity-Modulated 7Cisplatin 7Surveys and Questionnaires 6Educational Status 6Early Intervention, Educational 6Carboplatin 6Vaginal Smears 5Vaccines, Synthetic 5Methods 5Engerix-B 4fludarabine 3epigallocatechin gallate 3artesunic acid 3artemisinin 3Watchful Waiting 3Polymerase Chain Reaction 3Patient Navigation 3Paclitaxel 3Observation 3Mass Screening 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Papillomavirus Infections × Human Papillomavirus DNA Tests × Clear all
NCT06498661 2026-05-13

SHIP-A-S01

National Cancer Institute (NCI)

Phase NA Active not recruiting
750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

National Cancer Institute (NCI)

Phase NA Recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07244315 2026-01-21

Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology

University Hospital, Geneva

Completed
500 enrolled
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT04794660 2024-03-13

CESTA

International Agency for Research on Cancer

Phase 3 Unknown
1,500 enrolled

Papillomavirus Infections

NCT03713736 2021-07-27

PAPLOR

Hospices Civils de Lyon

Phase NA Unknown
385 enrolled

Spondylarthritis, Papillomavirus Infections

NCT02811367 2016-10-17

The HPV Self-test as a Test of Cure in Madagascar

University Hospital, Geneva

Phase NA Completed
117 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡